about
Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney CancerAlpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenationStromal Claudin14-heterozygosity, but not deletion, increases tumour blood leakage without affecting tumour growthEag and HERG potassium channels as novel therapeutic targets in cancerUbiquitin-specific protease 19 (USP19) regulates hypoxia-inducible factor 1α (HIF-1α) during hypoxiaDifferentiation in neuroblastoma: diffusion-limited hypoxia induces neuro-endocrine secretory protein 55 and other markers of a chromaffin phenotypeNovel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomasSomatic HIF2A gain-of-function mutations in paraganglioma with polycythemiaNegative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesisLinks between metabolism and cancerHypoxia-inducible factors and the response to hypoxic stressThe dual role of complement in cancer and its implication in anti-tumor therapyCancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer TherapyClinical significance of T cell metabolic reprogramming in cancerThe Landscape of Pancreatic Cancer Therapeutic Resistance MechanismsT Cells and Cancer: How Metabolism Shapes ImmunityHypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic ChangesDiverse Mechanisms of Sp1-Dependent Transcriptional Regulation Potentially Involved in the Adaptive Response of Cancer Cells to Oxygen-Deficient ConditionsMYC, Metabolism, and CancerSuccinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and EpigeneticsIncreased Oxidative Stress as a Selective Anticancer TherapyThe Effect of Hypoxia on Mesenchymal Stem Cell BiologyHypoxic signaling during tissue repair and regenerative medicineSignaling regulation of fetoplacental angiogenesisEpigenetic regulation by histone demethylases in hypoxiaAdvances of hypoxia and lung cancerNeoadjuvant therapy for pancreas cancer: past lessons and future therapiesCancer cell metabolism: implications for therapeutic targetsRadiotherapy and the tumor stroma: the importance of dose and fractionationHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionA Comparative pO2 Probe and [18F]-Fluoro-Azomycinarabino-Furanoside ([18F]FAZA) PET Study Reveals Anesthesia-Induced Impairment of Oxygenation and Perfusion in Tumor and MuscleHIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epitheliumHypoxia imaging endoscopy equipped with laser light source from preclinical live animal study to first-in-human subject researchA high-content image-based method for quantitatively studying context-dependent cell population dynamicsA novel microfluidic platform for studying mammalian cell chemotaxis in different oxygen environments under zero-flow conditions.Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia.The multifaceted roles of autophagy in tumors-implications for breast cancer.HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapyPHD2: from hypoxia regulation to disease progression
P2860
Q21090542-2FC5A3AE-7134-44B2-9945-3DC7E2F0A421Q21133512-CCBE3BCD-3CE3-41BC-8311-59EA6CDB749EQ21133542-15CE680E-2ABD-4639-AA45-55CABE9D42A9Q21245576-C5743630-7BA1-4EB2-9AF8-C6EFD167E781Q24298656-19E0D4A7-8BBB-4FC9-AD3D-D4F6496C7CA7Q24300732-1FEB922B-F4F3-4B09-9930-28E73ECD2D3EQ24597432-8F50072D-1A39-420E-94FC-537C738DC92EQ24607557-39D78777-899E-4499-A482-F167542CCD1AQ24620427-90581E19-26FE-4E4A-BE36-6EDCA2529BDEQ24626229-010A213D-44B6-41F1-8CEC-FA4A11FF7324Q24629323-F2869F5C-9859-4E57-BDCE-600081DCB260Q26738682-3DB540A7-4811-41B5-A860-29C91807E29DQ26740207-7AEFD41D-2F83-4A2E-865F-BB8B84618890Q26741974-54825DAD-A066-4DF3-A065-5732E0A5312BQ26765247-CFE88E30-2D8A-42BD-AB0B-D86445C5A83FQ26766427-44DEF730-916F-40B1-8940-5F46E783120CQ26767183-955BF784-3B56-421F-AE80-7A0E91C7FC66Q26771998-87278B92-1B7A-4C7B-A6B9-5F850A832428Q26783555-A17741A6-CB51-4204-BBF7-F19CB5C24096Q26796203-9DC3ABAA-3642-48B7-B9F7-E827EE4EFD56Q26798210-790EC1C7-6C68-45F8-8439-65AA53BD6733Q26799883-2FACC84B-7A9C-444C-8BC7-A1C7AC92BD9AQ26824402-AA065907-7E9E-47A7-AAB4-23B9F8AF6B47Q26825677-C3D6D18C-99FD-4758-B0C4-D30B936A3764Q26825704-F4ABBC01-F5FD-4775-AE91-98EC3AB715D2Q26860343-D3A9BD04-BCE2-4C59-8D82-2EA0FBEEA7ECQ27004292-211EF740-622F-4A0A-A42A-3B17F022DA62Q27013632-75C79815-D77D-43DE-B643-367B798698B8Q27022685-F5173461-BDC0-4344-A600-0969D9926D34Q27025886-2A41A4F2-3F01-4A13-8CF9-8BCD4E780137Q27308982-5DB136E8-0344-49F0-8EF9-EACFC522CDA0Q27316863-8973C2A2-CDAB-45CC-B330-55CEF836359CQ27324498-F998BD67-8E43-46AF-BF42-2EEFD8305A7FQ27329172-A104A899-8161-4C4D-AD97-F50DCEE1ED71Q27330270-12502AF8-8B7B-4A6D-96B5-24B5550D02C0Q27334035-A1AAE9FB-8CDF-431C-B543-C4C120499E14Q27692102-FA2BFA2F-05AF-4AD9-A4E8-5488ECC4AF6FQ27851557-4FBC7FD2-F7AA-46D1-A5F0-BBE807D3FF94Q28067724-5E29A51F-B82F-4BBC-B85D-24F32C005D6FQ28069316-B37F2216-7F68-443F-9CA4-7036DE8DE6CE
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The impact of O2 availability on human cancer
@ast
The impact of O2 availability on human cancer
@en
type
label
The impact of O2 availability on human cancer
@ast
The impact of O2 availability on human cancer
@en
prefLabel
The impact of O2 availability on human cancer
@ast
The impact of O2 availability on human cancer
@en
P2093
P2860
P3181
P356
P1476
The impact of O2 availability on human cancer
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/NRC2540
P407
P577
2008-12-01T00:00:00Z
P5875
P6179
1029171620